SectorBiological Technology
Established Date27/11/2013
Listing Date12/06/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees507
Fiscal Year Ends31/12
Security TypeCommon stock
Office address825 Industrial Road, Suite 300, San Carlos, California 94070
Business
IntroductionVaxcyte, Inc., was incorporated in Delaware on November 27, 2013. The company is a next-generation vaccine company that aims to improve global health by developing novel vaccines to prevent or treat some of the world's most common and deadly infectious diseases. Their cell-free protein synthesis platform enables them to design and produce protein carriers and antigens, which are key components of vaccines.
